Klaas Bakker
No más puestos en curso
Fortuna: 63 830 $ al 31/03/2024
42 años
Health Technology
Consumer Services
Perfil
Klaas Bakker is currently the Chief Medical Officer & Executive Vice President at Oncopeptides AB since 2019.
Prior to this, he worked as the Vice President-Medical Affairs at AstraZeneca PLC.
He holds a doctorate degree from the University of Groningen.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ONCOPEPTIDES AB
0.12% | 04/05/2023 | 105 000 ( 0.12% ) | 63 830 $ | 31/03/2024 |
Antiguos cargos conocidos de Klaas Bakker.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
| ONCOPEPTIDES AB | Chief Tech/Sci/R&D Officer | - |
Formación de Klaas Bakker.
| University of Groningen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
- Bolsa de valores
- Insiders
- Klaas Bakker
